ZFN-based disruption of both the two endogenous TCRβ constant (TRBC1 and TRBC2) and the TCRα constant (TRAC) regions, followed by lentiviral transduction with a transgenic WT-1-specific TCR-produced tumor, redirected T cells without endogenous TCR specificities [166]. This evidence concerns the gene TRAC and neoplasm.